Pfizer: Innovative Oral Treatment Options for Patients
Pfizer Cordially Invites You to Attend An Informational Program
Innovative Oral Treatment Options for Patients: HR+/HER2- MBC or gBRCA-Mutated TNBC and HR+/HER2- MBC
RENA CALLAHAN, MD
Assistant Clinical Professor of Medicine University of California Los Angeles
Please RSVP to your Pfizer Representative
Kindly provide your full name, degree, specialty, address including state, and email address when registering so that you can be confirmed. Please also provide the Meeting ID#INT-0047364 when you RSVP.